Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3022373 | 1.00 | CCR1 (0.57) | CCR1NR1I2 | |
| SCHEMBL3024810 | 0.88 | CCR1 (0.56) | CCR1 | |
| SCHEMBL1604149 | 0.84 | CCR1 (0.60) | CCR1NR1I2 | |
| SCHEMBL10291824 | 0.84 | CCR1 (0.69) | CCR1 | |
| SCHEMBL3023397 | 0.83 | CCR1 (0.58) | CCR1NR1I2 | |
| SCHEMBL2159504 | 0.83 | CCR1 (0.56) | CCR1NR1I2 | |
| SCHEMBL3017758 | 0.82 | CCR1 (0.60) | CCR1 | |
| SCHEMBL3017756 | 0.82 | CCR1 (0.60) | CCR1 | |
| Hydrochloric Acid SCHEMBL3950009 | 0.81 | CCR1 (0.59) | CCR1 | |
| SCHEMBL17520851 | 0.81 | CCR1 (0.60) | CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8501782-B2 | Piperidinyl derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-08-06 | — | — | US | disclosed |
| US-20100204274-A1 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2010-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204274-A1 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | CCR2, CXCR1, CCR1 | CCR1 3/4885NR1I2 248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.